Rosetta Genomics (ROSG) Misses Q1 EPS by 2c

Rosetta Genomics (NASDAQ: ROSG) reported Q1 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $3.36 million.

For earnings history and earnings-related data on Rosetta Genomics (ROSG) click here.

You May Also Be Interested In

• Verizon to cut 3,000 jobs as it shifts stores to franchises
• Simmons First National Corp (SFNC) Misses Q2 EPS by 2c
• Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue